mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
0.9 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
1 |